Number of patients who received a service with the main diagnosis C32 (laryngeal cancer) or the main diagnosis Z51 and the comorbid diagnosis C32, and the value of benefits: Difference between revisions

From Beacon
No edit summary
No edit summary
Line 2: Line 2:
{{forresearchers}}
{{forresearchers}}


'''Type of Information''': [[availableVariable::year]]; [[availableVariable::sex]]; [[availableVariable::age]] group; Type of benefit; [[availableVariable::costs reimbursement|Refund value]] and [[availableVariable::number of patients]].
'''Type of Information''': [[availableVariable::year]]; [[availableVariable::sex]]; [[availableVariable::age]] group; [[availableVariable::health service utilization|Type of benefit]]; [[availableVariable::costs reimbursement|Refund value]] and [[availableVariable::number of patients]].


'''Source of Information''': Data prepared on the basis of data from the National Health Fund headquarters as of 2021-11-10.
'''Source of Information''': Data prepared on the basis of data from the National Health Fund headquarters as of 2021-11-10.

Revision as of 13:39, 8 December 2023

Go back to Poland page

Type of Information: year; sex; age group; Type of benefit; Refund value and number of patients.

Source of Information: Data prepared on the basis of data from the National Health Fund headquarters as of 2021-11-10.

Data level: national level.

Number of Records: unknown.

Date Range: 2013-2020.

Cancer Areas of Interest: laryngeal cancer (C32); encounter for other aftercare and medical care (Z51).

Open data access: publicly available [1].

Information/Contact for data request: Contact information [2].